Inte, Recil R.

HRN: 19-85-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2024
CEFUROXIME 1.5GM (VIAL)
04/12/2024
04/19/2024
IV
1.5g
Q8
Maternal Fever Etbd
Checking Final Appropriateness 
05/17/2024
AMPICILLIN 1GM (VIAL)
05/17/2024
05/24/2024
IV
2gm
Q6 Until Delivery
Prom Thinly Meconium
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: